These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32586150)

  • 1. CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics.
    Carlaw TM; Zhang LH; Ross CJD
    Hum Gene Ther; 2020 Aug; 31(15-16):794-807. PubMed ID: 32586150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications.
    Molla KA; Yang Y
    Trends Biotechnol; 2019 Oct; 37(10):1121-1142. PubMed ID: 30995964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.
    Wu SS; Li QC; Yin CQ; Xue W; Song CQ
    Theranostics; 2020; 10(10):4374-4382. PubMed ID: 32292501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG.
    Yu SY; Birkenshaw A; Thomson T; Carlaw T; Zhang LH; Ross CJD
    CRISPR J; 2022 Apr; 5(2):187-202. PubMed ID: 35238621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.
    Givens BE; Naguib YW; Geary SM; Devor EJ; Salem AK
    AAPS J; 2018 Oct; 20(6):108. PubMed ID: 30306365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic Principles and Clinical Applications of CRISPR-Based Genome Editing.
    Lim JM; Kim HH
    Yonsei Med J; 2022 Feb; 63(2):105-113. PubMed ID: 35083895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
    Anzalone AV; Koblan LW; Liu DR
    Nat Biotechnol; 2020 Jul; 38(7):824-844. PubMed ID: 32572269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR base editors: genome editing without double-stranded breaks.
    Eid A; Alshareef S; Mahfouz MM
    Biochem J; 2018 Jun; 475(11):1955-1964. PubMed ID: 29891532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glance at genome editing with CRISPR-Cas9 technology.
    Barman A; Deb B; Chakraborty S
    Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
    Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
    J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing.
    Saber Sichani A; Ranjbar M; Baneshi M; Torabi Zadeh F; Fallahi J
    Mol Biotechnol; 2023 Jun; 65(6):849-860. PubMed ID: 36547823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-Based Genome Editing Toolbox for Arabidopsis thaliana.
    Miki D; Zinta G; Zhang W; Peng F; Feng Z; Zhu JK
    Methods Mol Biol; 2021; 2200():121-146. PubMed ID: 33175375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases.
    Testa LC; Musunuru K
    BioDrugs; 2023 Jul; 37(4):453-462. PubMed ID: 37314680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites.
    Tao J; Wang Q; Mendez-Dorantes C; Burns KH; Chiarle R
    Nat Commun; 2022 Jun; 13(1):3685. PubMed ID: 35760782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
    Jiang C; Meng L; Yang B; Luo X
    Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo somatic cell base editing and prime editing.
    Newby GA; Liu DR
    Mol Ther; 2021 Nov; 29(11):3107-3124. PubMed ID: 34509669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 genome engineering in hematopoietic cells.
    Sürün D; von Melchner H; Schnütgen F
    Drug Discov Today Technol; 2018 Aug; 28():33-39. PubMed ID: 30205879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.